Joseph E. Payne

Joseph E. Payne

President and Chief Executive Officer, DirectoratArcturus Therapeutics Holdings· In proxies 2021–2025

Pay in FY2025-54% from the year before · Arcturus Therapeutics Holdings stock -63.9% the same year

Joseph E. Payne was paid $1.7M in FY2025 (Dec), down 54%. Arcturus Therapeutics Holdings stock fell 63.9% that year.

Pay$100 in the stock at the end of FY20 → $14
Pay is from the Summary Compensation Table of each Arcturus Therapeutics Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Arcturus Therapeutics HoldingsPublic company · 5 yr
    • President and Chief Executive Officer, Director2021 – Present · 5 yrStock in role -88%
  2. Vallon Pharmaceuticals Inc.Public company
    • Director? – 2023No stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?